Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Smoking and Tobacco
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://www.ncbi.nlm.nih.gov/pubmed/23794597
http://dx.doi.org/10.1136/bmjopen-2013-003052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://www.ncbi.nlm.nih.gov/pubmed/23794597
http://dx.doi.org/10.1136/bmjopen-2013-003052

Ejemplares similares